GLAXOSMITHKLINE, LLC: $18.2M Department of Health and Human Services Contract
Summary
This $18.2M contract to private entity GlaxoSmithKline for Relenza stockpiling supports pandemic preparedness but does not directly impact any publicly traded company.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Private entity contract; no direct public equity exposure.
- 2.Contract supports ongoing pandemic preparedness efforts.
- 3.No material market implications from this award.
Market Implications
This contract has negligible direct market implications. No publicly traded tickers are linked. Investors should watch for similar but public awards in the influenza antiviral space.
Full Analysis
The Department of Health and Human Services awarded GlaxoSmithKline, LLC a $18.2M definitive contract for Relenza (zanamivir) Rotadisk, 5mg, for the period 2025-2027. Relenza is an influenza antiviral drug used for treatment and prophylaxis. The award is classified as a National Stockpile-related procurement under the Office of Assistant Secretary for Preparedness and Response. Despite the size, GlaxoSmithKline, LLC is not a publicly traded entity; it is a private limited liability company. No mapping to public tickers is possible without speculation. The contract supports broader biodefense and public health preparedness, a sector showing bipartisan support. Related bills like HR8840 (Fair Care Act) propose healthcare cost reforms but have low relevance to this specific antiviral procurement. Because the recipient is private, no supply chain or competitive beneficiaries can be reliably identified. The contract is routine and does not signal a shift in sector dynamics.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
FLOSONICS MEDICAL LLC: $15.0M Department of Health and Human Services Contract
ORE FINANCIAL SERVICES LLC: $10.5M Department of Justice Contract
ARDENT GROUP, LLC: $42.6M Department of Homeland Security Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
GLAXOSMITHKLINE, LLC
Award Amount
$18,199,980
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →